Corporate Announcement
Security Code : 531633    Company : LINCOPH    
 
Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On September 30, 2019 Along With Any Other Business, If Any.Download PDFDownload XBRL
  Exchange Received Time  04/11/2019 17:05:41         Exchange Disseminated Time   04/11/2019 17:05:48              Time Taken   00:00:07
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter Ended on September 30, 2019 along with any other business, if any.

Further, in continuation to our disclosure on Closure of Trading Window dated September 30, 2019, pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading, it may be noted that the trading window has been closed for Designated Persons viz Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons from September 30, 2019 and shall reopen after the expiry of 48 hours from the time the result becomes generally available.
 

Disclaimer

Back To Announcements